MYRIAD GENETICS INC Insider Trading for September 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MYRIAD GENETICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in MYRIAD GENETICS INC for September 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Sell | D | 12.44 | 2,218 | 27,592 | 51,167 | 53.4 K to 51.2 K (-4.15 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Sell | D | 12.44 | 1,664 | 20,700 | 53,385 | 55 K to 53.4 K (-3.02 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Hart Jayne B. | Executive VP Human ... | Sell | D | 12.44 | 2,218 | 27,592 | 55,049 | 57.3 K to 55 K (-3.87 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Parkinson Paul | EVP Strategy and In ... | Sell | D | 12.44 | 3,327 | 41,388 | 69,058 | 72.4 K to 69.1 K (-4.60 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Parkinson Paul | EVP Strategy and In ... | Sell | D | 12.44 | 2,218 | 27,592 | 72,385 | 74.6 K to 72.4 K (-2.97 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Parkinson Paul | EVP Strategy and In ... | Sell | D | 12.44 | 2,218 | 27,592 | 74,603 | 76.8 K to 74.6 K (-2.89 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Jackson Benjamin | E.V.P., General Cou ... | Sell | D | 12.44 | 2,935 | 36,511 | 58,782 | 61.7 K to 58.8 K (-4.76 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Jackson Benjamin | E.V.P., General Cou ... | Sell | D | 12.44 | 453 | 5,635 | 61,717 | 62.2 K to 61.7 K (-0.73 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Jackson Benjamin | E.V.P., General Cou ... | Sell | D | 12.44 | 367 | 4,565 | 62,170 | 62.5 K to 62.2 K (-0.59 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | President, MGL | Sell | D | 12.44 | 2,935 | 36,511 | 62,592 | 65.5 K to 62.6 K (-4.48 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | President, MGL | Sell | D | 12.44 | 2,935 | 36,511 | 62,592 | 65.5 K to 62.6 K (-4.48 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | President, MGL | Sell | D | 12.44 | 628 | 7,812 | 65,527 | 66.2 K to 65.5 K (-0.95 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | President, MGL | Sell | D | 12.44 | 628 | 7,812 | 65,527 | 66.2 K to 65.5 K (-0.95 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | President, MGL | Sell | D | 12.44 | 13 | 162 | 66,155 | 66.2 K to 66.2 K (-0.02 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | President, MGL | Sell | D | 12.44 | 13 | 162 | 66,155 | 66.2 K to 66.2 K (-0.02 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | President, MGL | Sell | D | 12.44 | 628 | 7,812 | 66,168 | 66.8 K to 66.2 K (-0.94 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Lambert Nicole | President, MGL | Sell | D | 12.44 | 628 | 7,812 | 66,168 | 66.8 K to 66.2 K (-0.94 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Verratti Mark | President Assurex H ... | Sell | D | 12.44 | 2,376 | 29,557 | 111,156 | 113.5 K to 111.2 K (-2.09 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Verratti Mark | President Assurex H ... | Sell | D | 12.44 | 2,376 | 29,557 | 111,156 | 113.5 K to 111.2 K (-2.09 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Verratti Mark | President Assurex H ... | Sell | D | 12.44 | 2,897 | 36,039 | 113,532 | 116.4 K to 113.5 K (-2.49 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Verratti Mark | President Assurex H ... | Sell | D | 12.44 | 2,897 | 36,039 | 113,532 | 116.4 K to 113.5 K (-2.49 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Verratti Mark | President Assurex H ... | Sell | D | 12.44 | 2,897 | 36,039 | 116,429 | 119.3 K to 116.4 K (-2.43 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Verratti Mark | President Assurex H ... | Sell | D | 12.44 | 2,897 | 36,039 | 116,429 | 119.3 K to 116.4 K (-2.43 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Verratti Mark | President Assurex H ... | Grant | A | 0.00 | 32,800 | 0 | 119,326 | 86.5 K to 119.3 K (+37.91 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Verratti Mark | President Assurex H ... | Grant | A | 0.00 | 32,800 | 0 | 119,326 | 86.5 K to 119.3 K (+37.91 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | Chief Operating Off ... | Sell | D | 12.44 | 4,546 | 56,552 | 175,693 | 180.2 K to 175.7 K (-2.52 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | Chief Operating Off ... | Sell | D | 12.44 | 5,267 | 65,521 | 180,239 | 185.5 K to 180.2 K (-2.84 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | Chief Operating Off ... | Sell | D | 12.44 | 6,653 | 82,763 | 185,506 | 192.2 K to 185.5 K (-3.46 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | Chief Operating Off ... | Grant | A | 0.00 | 41,000 | 0 | 192,159 | 151.2 K to 192.2 K (+27.12 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | D | 12.44 | 3,627 | 45,120 | 212,923 | 216.6 K to 212.9 K (-1.67 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | D | 12.44 | 4,214 | 52,422 | 216,550 | 220.8 K to 216.6 K (-1.91 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | D | 12.44 | 5,544 | 68,967 | 220,764 | 226.3 K to 220.8 K (-2.45 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Grant | A | 0.00 | 32,800 | 0 | 226,308 | 193.5 K to 226.3 K (+16.95 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Riggsbee Richard Bryan | Chief Financial Off ... | Sell | D | 12.44 | 4,546 | 56,552 | 280,025 | 284.6 K to 280 K (-1.60 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Riggsbee Richard Bryan | Chief Financial Off ... | Sell | D | 12.44 | 6,653 | 82,763 | 284,571 | 291.2 K to 284.6 K (-2.28 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Riggsbee Richard Bryan | Chief Financial Off ... | Sell | D | 12.44 | 5,267 | 65,521 | 291,224 | 296.5 K to 291.2 K (-1.78 %) |
| Sep 28 2020 | MYGN | MYRIAD GENETICS IN ... | Riggsbee Richard Bryan | Chief Financial Off ... | Grant | A | 0.00 | 41,000 | 0 | 296,491 | 255.5 K to 296.5 K (+16.05 %) |
| Sep 18 2020 | MYGN | MYRIAD GENETICS IN ... | Kumar Rashmi | Director | Grant | A | 0.00 | 23,923 | 0 | 23,923 | 0 to 23.9 K |
| Sep 16 2020 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | Chief Operating Off ... | Sell | S | 13.78 | 2,804 | 38,630 | 151,159 | 154 K to 151.2 K (-1.82 %) |